SNAP47 and Stroke: A large prospective cohort study demonstrated that elevated sVAP-1 levels are strongly associated with an increased risk of major adverse cardiovascular events (MACE), including CHD, unstable angina, acute myocardial infarction, coronary revascularization, and stroke (109).